Abstract. Certain compounds that prolong QT interval in humans have little or no effect on action-potential (AP) duration used traditionally, but they inhibit rapidly-activated-delayedrectifier potassium currents (I Kr ) and / or human ether-a-go-go-related gene (hERG) currents. In this study using isolated guinea-pig papillary muscles, we investigated whether new parameters in AP assays can detect the inhibitory effects of various compounds on I Kr and / or hERG currents with high sensitivity. The difference in AP duration between 60% and 30% repolarization, 90% and 60% repolarization, and 90% and 30% repolarization (APD 30-60 , APD 60-90 , and APD 30-90 , respectively) were calculated as the new parameters. All the 15 I Kr and / or hERG current inhibitors that have been reported (9 compounds) or not reported (6 compounds) to inhibit calcium currents prolonged APD 30-60 , APD 60-90 , and / or APD 30-90 ; and 8 of the 15 inhibitors prolonged APD 30-60 , APD 60-90 , and / or APD 30-90 more potently than APD 90 . The APD 30-60 , APD 60-90 , and APD 30-90 measurements revealed no difference in sensitivity when evaluating the effects of the I Kr and / or hERG current inhibitors on the three parameters. On the other hand, compounds with little or no effect on hERG currents had no effect on APD 30-60 , APD . Therefore, it is concluded that in AP assays using isolated guinea-pig papillary muscles, APD 30-60 , APD 60-90 , and APD 30-90 are useful indexes for evaluating the inhibitory effects of compounds including mixed ion-channel blockers on I Kr and / or hERG currents. Supplementary material (Appendix): available only at http://dx
Introduction
Many non-cardiac drugs have recently been shown to prolong electrocardiographic QT interval, leading to life-threatening ventricular arrhythmia, torsade de pointes (TdP) in humans (1, 2) . Therefore, the S7B guidelines of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use recommend the conducting of in vitro I Kr assay and in vivo QT assays to evaluate the potential of compounds to cause delayed ventricular repolarization (QT interval prolongation) (3) . It is well known that QT interval correlates with actionpotential (AP) duration in ventricular muscles and Purkinje fibers. Accordingly, AP assays using isolated ventricular muscles and Purkinje fibers have been used to evaluate the potential of compounds to cause QT interval prolongation. AP is composed of various inward and outward ion currents such as sodium, calcium, and potassium currents (Fig. 1) ; and the effects of a compound on AP parameters can predict its effects on each ion current. In isolated guinea-pig papillary muscles, astemizole and terfenadine, two second generation antihistamines, and pimozide, an antipsychotic agent, have been reported to have little or no effect on AP duration at 90% repolarization (APD 90 ), a parameter traditionally used in AP assays (4) . However, these drugs have been shown to prolong QT interval in humans and inhibit rapidly-activated-delayed-rectifier potassium currents (I Kr ) and / or I Kr -like human ether-ago-go-related gene (hERG) currents (1) . These results indicate that APD 90 alone is not reliable enough for evaluating the inhibitory effects of compounds on I Kr and/ or hERG currents.
In isolated rabbit hearts, many I Kr and / or hERG current inhibitors have been shown to prolong monophasic AP duration between 30% to 90% repolarization but not between 10% to 30% repolarization (5, 6) . Furthermore, it has been reported that dofetilide, a potent hERG current inhibitor (7, 8) , prolongs not only AP duration but also the difference between AP duration at 90% repolarization and that at 40% repolarization in isolated rabbit Purkinje fibers (9) . These results suggest that determining whether a compound prolongs the difference in AP duration between fixed points of repolarization can help predict its inhibitory effects on I Kr and / or hERG currents and consequently its potential for QT interval prolongation. It has been reported that nifedipine, a potent calcium channel blocker, reduces APD-prolongation induced by dofetilide. This finding suggests that inhibition of inward calcium current (I Ca ) attenuates APD-prolongation induced by I Kr and / or hERG current inhibitors. Recently, a new mathematical model of membrane excitation, the Kyoto Model, has been proposed to clarify the role of various ion channels in membrane excitability in ventricular cells (10) . Using the Kyoto Model, we calculated major ionic currents contributing to the formation of AP in ventricular cells electrically driven at 1.0 Hz ( Table 1 ) and showed that the contribution of I Ca in APD 60-90 formation is much lower than that in APD or APD and that APD 60-90 is a suitable AP parameter to detect inhibition of hERG currents by I Kr and / or hERG current inhibitors.
Using isolated guinea-pig papillary muscles, we investigated in this study whether new parameters in AP assays can detect the inhibitory effects of various compounds on I Kr and / or hERG currents with high sensitivity. The differences in AP duration between 60% and 30% repolarization, 90% and 60% repolarization, as well as 90% and 30% repolarization (APD , APD 60-90 , and APD , respectively) were calculated as the new parameters. However, it is worth noting here that a compound's potential for QT interval prolongation in humans should be assessed by integrating non-clinical, clinical, and other relevant information. It is, therefore, difficult to evaluate the safety of each compound in humans based only on the results of this study.
Materials and Methods

Electrophysiology
This study was performed in accordance with the Guidelines for the Care and Use of Animals defined by the Internal Committee of Experimental Animals in each organization given in the list of authors' affiliations for this paper.
Details of AP assays are described in another paper in this issue (4) . Briefly, papillary muscles were excised from the right ventricles of male Hartley guinea pigs and placed in an organ bath. The preparations were superfused with Tyrode's solution (37.0 ± 0.5°C) equilibrated with a gas mixture of 95% O 2 and 5% CO 2 at a flow rate of 5 to 10 mL/ min. The preparations were then electrically stimulated by an electrical stimulator via an isolation unit at a frequency of 1 Hz with Each value shows the total ionic current area (pA × ms) calculated by the equations shown in reference [10] . Simulation conditions were as follows: extracellular sodium, potassium, and calcium concentrations were 152.4, 4, and 2 mmol/L, respectively. Stimulation and sampling frequencies were 1.0 Hz and 0.01 ms, respectively. Initial values were as follows: intracellular sodium, potassium, calcium, and adenosine 5'-triphosphate concentrations were 6.33, 141.75, 2.06 × 10
, and 4.48 mmol/L, respectively. Membrane potential was set at −94.05 mV. A negative value shows an inward ionic current. Note that current area for ICa and IKs in APD60-90 is much lower than that in APD30-60 or APD30-90 and that the ratio of IKr/IKs in APD60-90 is higher than that in APD30-60 or APD30-90. rectangular pulses of 1-ms duration whose voltage was 1.5 -2.5 times higher than the diastolic threshold. A glass microelectrode (10 -40 MΩ) filled with 3 mol / L KCl was used to measure transmembrane APs. The APs were amplified with an amplifier and recorded by an AP recording/ analysis system for a 30-min application period.
Test compounds
The 21 test compounds used in this study were divided into three groups: 1) I Kr and / or hERG current inhibitors reported to inhibit calcium currents: bepridil (11), cisapride (12), disopyramide (13) , flecainide (14) , haloperidol (15), pimozide (16) , quinidine (14, 17) , terfenadine (18, 19) , and verapamil (20); 2) I Kr and / or hERG current inhibitors not reported to inhibit calcium currents (21): astemizole, ciprofloxacin, E-4031, MK-499, dl-propranolol, and thioridazine; and 3) other compounds with little or no effect on hERG currents (21): amoxicillin, aspirin, captopril, diphenhydramine, lidocaine, and nifedipine.
Data analysis
APD , APD 60-90 , and APD were calculated as the differences in AP duration between 60% and 30%, 90% and 60%, and 90% and 30% repolarization, respec- 
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tively. Percent change in AP duration from the pretreatment value in each test-compound-treated group was compared to that in the vehicle-control group by the parametric Dunnett's test (2-tailed). Data are expressed as the mean ± S.E.M. Statistical significance was defined as P<0.05. Effects of compounds with little or no effect on hERG currents on APD 30-60 , APD 60-90 , and APD (Table 4 , Appendices 3-1 and 3-2)
Results
Absolute values of APD
Amoxicillin, aspirin, and captopril had no effect on 
Discussion
Of the 15 I Kr and / or hERG current inhibitors tested in this study, astemizole, bepridil, cisapride, disopyramide, E-4031, flecainide, haloperidol, MK-499, quinidine, and thioridazine prolonged APD , APD 60-90 , and APD by more than 10% of each pre-treatment value in isolated guinea-pig papillary muscles. These 10 inhibitors also prolonged APD 90 (4), although astemizole and bepridil only slightly prolonged APD 90 . Pimozide, dlpropranolol, terfenadine, and verapamil prolonged APD , APD , and / or APD . However, these four I Kr and / or hERG current inhibitors did not prolong APD 90 (4). Diphenhydramine, a weak I Kr blocker (22) , prolonged APD 60-90 and APD 30-90 but did not affect APD 90 (4). Amoxicillin, aspirin, captopril, lidocaine, and nifedipine did not prolong APD , APD 60-90 , or APD . It is well known that amoxicillin, aspirin, captopril, lidocaine, and nifedipine have little or no inhibitory effect on I Kr and / or hERG currents (21) . These results indicate that in isolated guinea-pig papillary muscles, the sensitivity of APD , APD 60-90 , and APD in detecting the inhibitory effects of compounds on I Kr and / or hERG currents is higher than that of APD 90 .
All the 15 I Kr and / or hERG current inhibitors prolonged APD 60-90 by more than 5% of each pre-treatment value (Table 5) , while 14 of these inhibitors (terfenadine excluded) prolonged APD 30-90 by more than 5% of each pre-treatment value. Thirteen I Kr and / or hERG current inhibitors (terfenadine and dl-propranolol excluded) prolonged APD 30-60 by more than 5% of each pretreatment value. Diphenhydramine prolonged APD 60-90 by more than 10% and APD 30-90 by 5% -10%, although this compound has been reported to moderately inhibit I Kr (22) . From our results calculated using the Kyoto Model (10), which is a new mathematical model of membrane excitation, it is suggested that the I Ca contribution in the formation of APD 60-90 is much lower than that in APD or APD . This hypothesis is supported by the fact that nifedipine, a calcium channel blocker, shortened APD 30-60 without affecting APD 60-90 . 
Data are expressed as the percent change from the pre-treatment value. Each value represents the mean ± S.E.M. of 6 experiments. *P<0.05, **P<0.01 vs vehicle by parametric Dunnett's test.
On the other hand, despite the fact that disopyramide (13) , quinidine (14, 17) , and pimozide (16) inhibit I Ca , they prolonged APD , APD 60-90 , and APD . Therefore, it is likely that evaluation of the effects of compounds on APD 30-60 , APD 60-90 , and APD can predict the inhibitory effects of mixed ion-channel blockers on I Kr and / or hERG currents, although no difference in sensitivity, when evaluating the inhibitory effects of mixed ion-channel blockers on hERG, can be expected between APD 30-60 , APD 60-90 , and APD 30-90 measurement.
Of the I Kr and / or hERG current inhibitors tested in our study, astemizole (23) , cisapride (24) , E-4031 (25), flecainide (26) , ciprofloxacin (27) , pimozide (28) , and quinidine (29) have been reported to inhibit I Kr or hERG currents with little or no effect on slowly-activateddelayed-rectifier potassium currents (I Ks ) or I Ks -like KvLQT1 / mink currents. On the other hand, the prolongation of APD and APD induced by cisapride at 1 µmol / L was greater than that of APD 60-90 . Furthermore, the concentrations of flecainide, thioridazine, and verapamil at which prolongation of APD and / or APD 30-90 occurred were lower than those at which prolongation of APD 60-90 was obtained. These findings indicate that when evaluating the inhibitory effects of compounds on hERG currents, measurements of APD , APD 60-90 , and APD 30-90 are highly sensitive and reliable.
Astemizole, bepridil, cisapride, haloperidol, terfenadine, and quinidine have been identified as compounds with proarrhythmic potential in the rabbit heart model (6). These findings support our results showing that these six compounds prolong APD , APD 60-90 , and / or APD . dl-Propranolol and verapamil prolonged APD , APD 60-90 , and / or APD 30-90 , although both compounds were identified as having no proarrhythmic activity in the rabbit heart model (6). It has been reported that dl-propranolol at therapeutic concentrations does not affect hERG currents (30) and that verapamil at therapeutic concentrations does not affect QT interval in humans (1) . These results suggest that evaluation of the 
Compounds with little or no effect on hERG current (3) . In addition, the guidelines encourage the enforcement of follow-up studies to detect a compound's potential for causing delayed ventricular repolarization. The results of this study suggest that the AP assay in isolated guinea-pig papillary muscles using APD , APD 60-90 , and APD 30-90 as parameters can help detect a compound's potential for inducing QT interval prolongation. However, despite the fact that dl-propranolol and verapamil have not induced excessive QT interval prolongation leading to TdP (1), both compounds prolonged APD 60-90 and APD . Therefore, the potential of compounds for QT interval prolongation in humans should be assessed by integrating non-clinical, clinical, and other relevant information.
In conclusion, APD , APD 60-90 , and APD in AP assays using isolated guinea-pig papillary muscles are useful indexes for evaluating the effects of compounds including mixed ion-channel blockers on I Kr and / or hERG currents.
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